PaeonidaninCAS# 209969-75-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
Cas No. | 209969-75-5 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C24H30O11 | M.Wt | 494.49 |
Type of Compound | Monoterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Paeonidanin Dilution Calculator
Paeonidanin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.0223 mL | 10.1114 mL | 20.2229 mL | 40.4457 mL | 50.5571 mL |
5 mM | 0.4045 mL | 2.0223 mL | 4.0446 mL | 8.0891 mL | 10.1114 mL |
10 mM | 0.2022 mL | 1.0111 mL | 2.0223 mL | 4.0446 mL | 5.0557 mL |
50 mM | 0.0404 mL | 0.2022 mL | 0.4045 mL | 0.8089 mL | 1.0111 mL |
100 mM | 0.0202 mL | 0.1011 mL | 0.2022 mL | 0.4045 mL | 0.5056 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Isotheaflavin
Catalog No.:BCX1053
CAS No.:31701-93-6
- 11-Methoxyyangonin
Catalog No.:BCX1052
CAS No.:2743-14-8
- Phenaxolactone 1
Catalog No.:BCX1051
CAS No.:147022-96-6
- 3'-O-Acetylhamaudol
Catalog No.:BCX1050
CAS No.:30358-88-4
- Pterostilbene glucoside
Catalog No.:BCX1049
CAS No.:38967-99-6
- 2"-Acetylhyperin
Catalog No.:BCX1048
CAS No.:439266-62-3
- Fischeroside C
Catalog No.:BCX1047
CAS No.:1307257-09-5
- Rhododenol
Catalog No.:BCX1046
CAS No.:69617-84-1
- Advantame
Catalog No.:BCX1045
CAS No.:714229-20-6
- Wilforlide B
Catalog No.:BCX1044
CAS No.:84104-70-1
- 13β,21-Dihydroxyeurycomanone
Catalog No.:BCX1043
CAS No.:138874-44-9
- L-1,2,3,4-Tetrahydronorharman-3-carboxylic acid
Catalog No.:BCX1042
CAS No.:42438-90-4
- Isohanalpinone
Catalog No.:BCX1055
CAS No.:103476-95-5
- 3-Fucosyllactose
Catalog No.:BCX1056
CAS No.:41312-47-4
- 5-Hydroxyferulic acid
Catalog No.:BCX1057
CAS No.:1782-55-4
- Phloretin 2'-xyloglucoside
Catalog No.:BCX1058
CAS No.:145758-09-4
- Myriacetin
Catalog No.:BCX1059
CAS No.:203734-35-4
- 2'-Fucosyllactose
Catalog No.:BCX1060
CAS No.:41263-94-9
- Paeoniflorin sulfite
Catalog No.:BCX1061
CAS No.:1146967-98-7
- (+)-Epitaxifolin
Catalog No.:BCX1062
CAS No.:153666-25-2
- Notoginsenoside ST4
Catalog No.:BCX1063
CAS No.:155683-02-6
- Podecdysone B
Catalog No.:BCX1064
CAS No.:22612-27-7
- Crocetine dimethyl ester
Catalog No.:BCX1065
CAS No.:5892-54-6
- Resveratrol 12-C-β-glucopyranoside
Catalog No.:BCX1066
CAS No.:163527-00-2
Monoterpene glycosides with anti-inflammatory activity from Paeoniae Radix.[Pubmed:31398448]
Fitoterapia. 2019 Oct;138:104290.
Six new monoterpene glycosides, named 6'-O-nicotinoylalbiflorin (1), 4'-O-vanillylalbiflorin (2), Paeonidanin L (3), paeoniflorigenin-1-O-beta-d-xyloside (4), 6'-(2-hydroxypropanoyl)-paeoniflorin (5), oxylactiflorin (6), together with 16known ones (7-22) were isolated from the 70% ethanol extract of Paeoniae Radix. Their structures were elucidated based on spectroscopic analysis (1D and 2D NMR, HRESIMS, IR and UV), chemical evidences and comparison with literatures. The inhibitory effects of all the isolates were evaluated against lipopolysaccharide (LPS) stimulated PGE(2) production in RAW 264.7 macrophages.
Anti-Inflammatory Effects, SAR, and Action Mechanism of Monoterpenoids from Radix Paeoniae Alba on LPS-Stimulated RAW 264.7 Cells.[Pubmed:28468284]
Molecules. 2017 Apr 29;22(5):715.
Nine monoterpenoids from Radix Paeoniae Alba, including paeoniflorin derivatives, paeoniflorin (PF), 4-O-methylpaeoniflorin (MPF), 4-O-methylbenzoylpaeoniflorin (MBPF); Paeonidanin derivatives, Paeonidanin (PD), Paeonidanin A (PDA), albiflorin derivatives, albiflorin (AF), benzoylalbiflorin (BAF), galloylalbiflorin (GAF), and debenzoylalbiflorin (DAF), were obtained in our previous phytochemistry investigations. Their anti-inflammatory effects were determined in the present study. The expression and production of pro-inflammatory cytokines in lipopolysaccharides (LPS)-stimulated RAW 264.7 cells were measured using an Elisa assay and nitric oxide (NO) release was determined using the Griess method. The results demonstrated that the most of the monoterpenoids suppressed the LPS-induced production of NO, interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-alpha). The anti-inflammatory activities of these monoterpenoids were closely related to their structural characteristics. Paeoniflorins and Paeonidanins presented stronger anti-inflammatory activities than those of albiflorin derivatives. Furthermore, the action mechanisms of MBPF, having a strong anti-inflammatory effect, were investigated using quantitative reverse transcription polymerase chain reaction (RT-PCR) and Western blot methods. The results indicated that MBPF could down-regulate the mRNA and protein expression level of inducible nitric oxide synthase (iNOS) in LPS-stimulated RAW 264.7 cells. The mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K)/AKT and nuclear factor kappaB (NF-kappaB) signaling pathways are involved in mediating the role of MBPF in suppressing the expression and production of pro-inflammatory cytokines in RAW 264.7 cells.
Monoterpene glycosides from Paeonia veitchii.[Pubmed:27268664]
J Asian Nat Prod Res. 2017 Jan;19(1):22-27.
The EtOH extract of the roots of Paeonia veitchii afforded two new monoterpene glycosides Paeonidanin I (1) and Paeonidanin J (2), and a new dimeric monoterpene glycoside Paeonidanin K (3). Their structures were elucidated on the basis of spectroscopic means and hydrolysis products.
Monoterpenes from Paeonia albiflora and their inhibitory activity on nitric oxide production by lipopolysaccharide-activated microglia.[Pubmed:19691309]
J Nat Prod. 2009 Sep;72(9):1579-84.
Eleven new monoterpenes, paeonidangenin (1), Paeonidanin A (2), Paeonidanin B (3), Paeonidanin C (4), Paeonidanin D (5), Paeonidanin E (6), paeoniflorone (7), 4-O-methylbenzoylpaeoniflorin (8), 4-O-methylgalloylpaeoniflorin (9), 4-O-methyldebenzoylpaeoniflorin (10), and 4-O-methylalbiflorin (11), were isolated from the 60% ethanol extract of the roots of Paeonia albiflora. Their structures were determined primarily on the basis of 1D and 2D NMR techniques and MS studies. Paeonidanins D (5) and E (6) are unprecedented examples of "cage-like" monoterpene dimers. The inhibitory effects of the isolated compounds on nitric oxide production by lipopolysaccharide (LPS)-activated N9 microglia were evaluated.
[Study on chemical constituents of bark of Paeonia suffruticosa].[Pubmed:17260795]
Zhongguo Zhong Yao Za Zhi. 2006 Nov;31(21):1793-5.
OBJECTIVE: To study the chemical constituents of the bark of Paeonia suffruticosa. METHOD: The 95% ethanol extract was re-extracted with EtOAc, and then separated and purified by column chromatography using silica gel, Sephadex LH -20 and RP-18 as packing materials. The structures were identified on the basis of spectral analysis and physico-chemical characters. RESULT: Six compounds were isolated and identified as (+)-catechin (1), Paeonidanin (2), paeoniflorigenone (3), 2, 5-dihydroxy-4-methoxyacetophenone (4), paeonol (5), gallic acid (6). CONCLUSION: The compound 1 was isolsted from the genus Paeonia for the first time. The compounds 2, 3 were isolated from this plant for the first time.
Vasorelaxant effect of the rootbark extract of Paeonia moutan on isolated rat thoracic aorta.[Pubmed:17051461]
Planta Med. 2006 Nov;72(14):1338-41.
The vascular relaxant effect of the rootbark extract of Paeonia moutan was evaluated in isolated rat thoracic aorta. The methanolic extract of the rootbark showed a vasorelaxant activity in rat aortic preparations precontracted with 0.3 microM phenylephrine (IC50 value: 16.8 microg/mL). The activity-guided fractionation of the extract led to the isolation of five active principles such as paeoniflorin (1), Paeonidanin (2), methylpaeoniflorin (4), tetragalloylglucose (5) and pentagalloylglucose (6), and these active ingredients potently relaxed phenylephrine-induced contraction of rat aortic preparations in a concentration-dependent manner (IC50 values: 19.4, 7.9, 10.1, 5.1 and 3.6 microM, respectively). These results suggest that pinane glycosides and galloylglucoses might be the components responsible for the vasorelaxant properties of the rootbark extract of P. moutan, and their vasorelaxant effects may be mediated through increases in the release of nitric oxide from endothelial cells.